The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour
<p>Abstract</p> <p>Background</p> <p>The proteolysis-inducing factor (PIF) was identified as a tumour product in various gastrointestinal cancers. A previous study in pancreatic cancer patients suggested PIF expression as a tumour marker, which is not related to tumour...
Main Authors: | Keim Volker, Mössner Joachim, Lochs Herbert, Kleeff Jörg, Teich Niels, Friess Helmut, Ockenga Johann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | BMC Gastroenterology |
Online Access: | http://www.biomedcentral.com/1471-230X/5/20 |
Similar Items
-
Hereditary chronic pancreatitis
by: Mössner Joachim, et al.
Published: (2007-01-01) -
Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
by: Helmut Friess, et al.
Published: (2011-02-01) -
Tumour associated proteolysis and protein metabolism
by: Smith, Kate L.
Published: (1992) -
A tumour specific antigen in the urine of patients with malignant melanoma
by: Bennett, M. C.
Published: (1978) -
Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
by: Sonja Gillen, et al.
Published: (2010-04-01)